Company Filing History:
Years Active: 2008-2011
Title: Hanns-Martin Schmidt: Innovator in Modular Transfection Systems
Introduction
Hanns-Martin Schmidt is a notable inventor based in Köln, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modular transfection systems. With a total of 2 patents, his work has the potential to impact gene therapy and pharmaceutical preparations.
Latest Patents
Schmidt's latest patents focus on a method for transfection of cells using proteins capable of forming nucleoprotein filaments. The process involves modifying the protein with functional components that influence transfection steps. The nucleic acid to be transfected is loaded with the modified protein, forming a filament-like complex that is then introduced to the target cells. This innovative approach also includes the development of a transfection agent consisting of nucleoprotein filaments, which can be utilized in producing drugs for gene therapeutic treatments in humans and animals. Furthermore, his inventions encompass pharmaceutical preparations for gene therapy and the use of transfection agents in kits.
Career Highlights
Throughout his career, Schmidt has worked with prominent companies in the biotechnology sector, including Lonza Cologne GmbH and Amaxa AG. His experience in these organizations has contributed to his expertise in transfection technologies and gene therapy applications.
Collaborations
Some of his notable coworkers include Ludger Altrogge and Dietmar Lenz. Their collaborative efforts have likely enhanced the development and implementation of innovative solutions in the field.
Conclusion
Hanns-Martin Schmidt's contributions to modular transfection systems represent a significant advancement in biotechnology. His patents and career achievements highlight his role as an influential inventor in the realm of gene therapy.